Interactive Financial Charts Not Available

Medtronic plc (MDT) | Financial Analysis & Statements

Medtronic plc | Large-cap | Healthcare

$93.02

1.13%

Medtronic plc vs Abbott Laboratories Medtronic plc vs Boston Scientific Medtronic plc vs Stryker Medtronic plc vs Edwards Lifesciences Medtronic plc vs Dexcom Medtronic plc vs S&P 500 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Apr 2025

Income Metrics

Revenue 8.9B

Gross Profit 5.8B 64.75%

Operating Income 1.8B 20.13%

Net Income 1.1B 11.89%

Balance Sheet Metrics

Total Assets 91.7B

Total Liabilities 43.4B

Shareholders Equity 48.3B

Debt to Equity 0.90

Cash Flow Metrics

Operating Cash Flow 2.1B

Free Cash Flow 2.1B

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Medtronic plc Income Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Revenue i	33.5B	32.4B	31.2B	31.7B	30.1B
Cost of Goods Sold i	11.6B	11.2B	10.7B	10.1B	10.5B
Gross Profit i	21.9B	21.1B	20.5B	21.5B	19.6B
Gross Margin % i	65.3%	65.3%	65.7%	68.0%	65.2%
Operating Expenses
Research & Development i	2.7B	2.7B	2.7B	2.7B	2.5B
Selling, General & Administrative i	10.8B	10.7B	10.4B	10.3B	10.1B
Other Operating Expenses i	-23.0M	464.0M	-131.0M	862.0M	315.0M
Total Operating Expenses i	13.6B	13.9B	13.0B	13.9B	13.0B
Operating Income i	6.5B	5.5B	5.8B	5.9B	4.9B
Operating Margin % i	19.5%	17.1%	18.7%	18.6%	16.3%
Non-Operating Items
Interest Income i	-	-	-	-	-
Interest Expense i	729.0M	719.0M	636.0M	553.0M	925.0M
Other Non-Operating Income	-182.0M	37.0M	170.0M	163.0M	-75.0M
Pre-tax Income i	5.6B	4.8B	5.4B	5.5B	3.9B
Income Tax i	936.0M	1.1B	1.6B	456.0M	265.0M
Effective Tax Rate % i	16.6%	23.4%	29.5%	8.3%	6.8%
Net Income i	4.7B	3.7B	3.8B	5.1B	3.6B
Net Margin % i	14.0%	11.4%	12.1%	16.0%	12.1%
Key Metrics
EBITDA i	9.8B	8.6B	9.0B	8.9B	7.9B
EPS (Basic) i	-	$2.77	$2.83	$3.75	$2.68
EPS (Diluted) i	-	$2.76	$2.82	$3.73	$2.66
Basic Shares Outstanding i	-	1327700000	1329800000	1342400000	1344900000
Diluted Shares Outstanding i	-	1327700000	1329800000	1342400000	1344900000

Income Statement Trend

Medtronic plc Balance Sheet From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Assets
Current Assets
Cash & Equivalents i	2.2B	1.3B	1.5B	3.7B	3.6B
Short-term Investments i	6.7B	6.7B	6.4B	6.9B	7.2B
Accounts Receivable i	6.5B	6.1B	6.0B	5.6B	5.5B
Inventory i	5.5B	5.2B	5.3B	4.6B	4.3B
Other Current Assets	2.9B	2.6B	2.4B	2.3B	2.0B
Total Current Assets i	23.8B	21.9B	21.7B	23.1B	22.5B
Non-Current Assets
Property, Plant & Equipment i	7.2B	6.4B	6.7B	6.5B	6.3B
Goodwill i	95.1B	95.2B	97.7B	96.6B	101.7B
Intangible Assets i	11.7B	13.2B	14.8B	15.6B	17.7B
Long-term Investments	-	-	-	-	-
Other Non-Current Assets	7.6B	7.7B	7.4B	6.4B	5.6B
Total Non-Current Assets i	67.9B	68.0B	69.3B	67.9B	70.5B
Total Assets i	91.7B	90.0B	90.9B	91.0B	93.1B
Liabilities
Current Liabilities
Accounts Payable i	2.4B	2.4B	2.7B	2.3B	2.1B
Short-term Debt i	2.9B	1.1B	20.0M	3.7B	11.0M
Current Portion of Long-term Debt	-	-	-	-	-
Other Current Liabilities	1.0M	-	-1.0M	-	-
Total Current Liabilities i	12.9B	10.8B	9.1B	12.4B	8.5B
Non-Current Liabilities
Long-term Debt i	25.6B	23.9B	24.3B	20.4B	26.4B
Deferred Tax Liabilities i	403.0M	515.0M	708.0M	884.0M	1.0B
Other Non-Current Liabilities	1.8B	1.4B	1.7B	1.4B	1.8B
Total Non-Current Liabilities i	30.5B	28.8B	30.2B	25.9B	33.0B
Total Liabilities i	43.4B	39.6B	39.3B	38.3B	41.5B
Equity
Common Stock i	0	0	0	0	0
Retained Earnings i	31.5B	30.4B	30.4B	30.2B	28.6B
Treasury Stock i	-	-	-	-	-
Other Equity	-	-	-	-	-
Total Shareholders Equity i	48.3B	50.4B	51.7B	52.7B	51.6B
Key Metrics
Total Debt i	28.5B	25.0B	24.4B	24.1B	26.4B
Working Capital i	10.9B	11.1B	12.6B	10.7B	14.0B

Balance Sheet Composition

Medtronic plc Cash Flow Statement From 2021 to 2025

Metric	2025	2024	2023	2022	2021
Operating Activities
Net Income i	4.7B	3.7B	3.8B	5.1B	3.6B
Depreciation & Amortization i	2.9B	2.6B	2.7B	2.7B	2.7B
Stock-Based Compensation i	429.0M	393.0M	355.0M	359.0M	344.0M
Working Capital Changes i	-1.3B	-875.0M	-1.7B	-1.1B	-1.2B
Operating Cash Flow i	6.7B	5.9B	5.2B	6.6B	5.3B
Investing Activities
Capital Expenditures i	-1.9B	-1.6B	-1.5B	-1.4B	-1.4B
Acquisitions i	-98.0M	-211.0M	-1.9B	-91.0M	-994.0M
Investment Purchases i	-8.2B	-7.7B	-7.5B	-9.9B	-11.8B
Investment Sales i	8.5B	7.4B	7.3B	9.7B	11.3B
Investing Cash Flow i	-1.9B	-2.4B	-3.5B	-1.7B	-2.9B
Financing Activities
Share Repurchases i	-3.2B	-2.1B	-645.0M	-2.5B	-652.0M
Dividends Paid i	-3.6B	-3.7B	-3.6B	-3.4B	-3.1B
Debt Issuance i	3.2B	0	5.4B	0	7.2B
Debt Repayment i	-1.1B	0	-8.3B	-1.0M	-10.5B
Financing Cash Flow i	-5.4B	-4.4B	-7.2B	-5.3B	-7.3B
Free Cash Flow i	5.2B	5.2B	4.6B	6.0B	4.9B
Net Change in Cash i	-656.0M	-881.0M	-5.5B	-435.0M	-4.9B

Cash Flow Trend

Medtronic plc Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 25.72

Forward P/E 15.87

Price to Book 2.48

Price to Sales 3.55

PEG Ratio 15.87

Profitability Ratios

Profit Margin 13.90%

Operating Margin 17.09%

Return on Equity 9.51%

Return on Assets 4.41%

Financial Health

Current Ratio 1.85

Debt to Equity 61.39

Beta 0.82

Per Share Data

EPS (TTM) $3.61

Book Value per Share $37.46

Revenue per Share $26.09

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
mdt	119.0B	25.72	2.48	9.51%	13.90%	61.39
Abbott Laboratories	229.3B	16.53	4.53	30.93%	32.43%	26.50
Boston Scientific	152.9B	61.41	6.81	11.55%	13.55%	53.09
Stryker	144.4B	50.16	6.81	14.25%	12.25%	80.83
Edwards Lifesciences	45.6B	32.50	4.33	15.53%	72.96%	6.62
Dexcom	31.4B	56.46	12.22	22.83%	13.29%	100.24

Financial data is updated regularly. All figures are in the company's reporting currency.